R&D
Pursuing Cutting Edge and Being the Second to None
Pursuing Cutting Edge and Being the Second to None
eSenso pursues only the cutting-edge technologies in the design of affordable, portable, and remotely controllable smart biosensors that are pain-free, hand-size, and easy-to-use, capable of monitoring continuous, real-time, and multiplex hematological and other metabolic and physiological biomarkers, especially effective and efficient for diabetic, cardiac or other complications of chronic health diseases. Not only that, eSenso has been dedicated to the development of artificial intelligence (AI) based smart bio-sensing and bio-transmitting biomarker devices (both electrochemical and optical) that go beyond the applications of medical industry. Recent three registrations with U.S. Patent Pending Protection demonstrate eSenso’s breakthrough innovations and achievements in testing and monitoring the key indicators of food, beverage, and drug manufacturing industries. These novel proprietary technological progresses traced from eSenso’s long and painstaking R&D track-records:
- Development of Ultrasensitive Electrochemical Immunosensor for Rapid Point-of-Care Covid-19 Detection
This project involves the design and development of an electrochemical immunoassay for point-of-care testing of Covid-19.
- Multiplex Electrochemical Immunosensor for Cardiac Biomarkers
The project involves the development of a multiplex cardiac marker electrochemical immunosensor prototype, for the simultaneous quantitative detection of human cardiac troponin I (cTnI), creatine kinase MB (CK-MB) and myoglobin for the rapid diagnosis and treatment of acute myocardial infarction (AMI).
- Diagnostic Aptamer Selection For The Beetle Pheromone Verbenone and Its Derivatives
The project involves the in vitro selection of DNA aptamer(s) with high sensitivity and specificity against verbenone, and the design of "Dexoxyribosensors" for sensing and quantitation of verbenone and related compounds.
- Development of an Electrochemical Immunosensor for Measurement of Troponin
The project involves the development of an electrochemical immunosensor prototype for the point-of-care measurement of human cardiac Troponin I.
- Electrochemical Biosensor-Based Diagnostic Medical Devices
The project involves the development of a single use multiplex electrochemical biosensor prototypes for the application of point-of-care (POC) testing.
- Electrochemical Synthesis and Characterization of Gold Nanoparticles
The project involves the development of innovative techniques to synthesize and characterize gold nanoparticles electrochemically.
- Develop Electrochemical Biosensor Prototypes for Point-of-care (POC) testing of analytes
The project involves the design and development of electrochemical biosensor prototypes for point-of-care (POC) testing of glycated hemoglobin (HbA1C), cholesterol, and ketone.
- A feasibility Study of an Electrochemical Sensor
The project involves the feasibility study of electrochemical biosensor in testing cholesterol, ketone, and glycated hemoglobin (HbA1c).
- Aptamer-based Electrochemical Sensor for Rapid and Quantitative Detection of Melamine
This project involves the development of a portable aptamer-based electrochemical sensor for the quantitation of melamine.